Prahlad R.  Singh net worth and biography

Prahlad Singh Biography and Net Worth

Insider of Revvity
Dr. Singh was elected President and Chief Executive Officer of PerkinElmer effective December 30, 2019, and appointed to our board of directors in August 2019. Previously Dr. Singh was the President and Chief Operating Officer of the Company since January 2019. Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014. He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018. Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East region. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals. He also currently serves on the Board of Directors of the Analytical, Life Science & Diagnostics Association (ALDA).

Dr. Singh has more than twenty-five years of leadership experience with global innovators in healthcare technology. He has spent the most recent six years developing unique insights into both our business and our opportunities for continued growth. Dr. Singh brings to our board a detailed understanding of the core technologies that we utilize and the operational strategies available to us as we continue to focus on innovating for a healthier world.

What is Prahlad R. Singh's net worth?

The estimated net worth of Prahlad R. Singh is at least $0.00 as of February 5th, 2024. Dr. Singh owns 92,801 shares of Revvity stock worth more than $0 as of March 28th. This net worth evaluation does not reflect any other investments that Dr. Singh may own. Learn More about Prahlad R. Singh's net worth.

How do I contact Prahlad R. Singh?

The corporate mailing address for Dr. Singh and other Revvity executives is 940 WINTER STREET, WALTHAM MA, 02451. Revvity can also be reached via phone at (781) 663-6900 and via email at [email protected]. Learn More on Prahlad R. Singh's contact information.

Has Prahlad R. Singh been buying or selling shares of Revvity?

Prahlad R. Singh has not been actively trading shares of Revvity during the past quarter. Most recently, Prahlad R. Singh sold 10,636 shares of the business's stock in a transaction on Tuesday, January 5th. The shares were sold at an average price of $150.00, for a transaction totalling $1,595,400.00. Following the completion of the sale, the insider now directly owns 50,537 shares of the company's stock, valued at $7,580,550. Learn More on Prahlad R. Singh's trading history.

Who are Revvity's active insiders?

Revvity's insider roster includes Peter Barrett (Director), Joel Goldberg (Insider), Sylvie Gregoire (Director), Maxwell Krakowiak (Insider), James Mock (Insider), Andrew Okun (Insider), Prahlad Singh (Insider), Daniel Tereau (Insider), and Tajinder Vohra (Insider). Learn More on Revvity's active insiders.

Are insiders buying or selling shares of Revvity?

During the last twelve months, insiders at the medical research company sold shares 3 times. They sold a total of 4,608 shares worth more than $624,165.36. The most recent insider tranaction occured on April, 13th when insider Andrew Okun sold 2,435 shares worth more than $332,401.85. Insiders at Revvity own 0.5% of the company. Learn More about insider trades at Revvity.

Information on this page was last updated on 4/13/2023.

Prahlad R. Singh Insider Trading History at Revvity

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2021Sell10,636$150.00$1,595,400.0050,537View SEC Filing Icon  
4/9/2019Sell3,289$102.39$336,760.7128,242View SEC Filing Icon  
2/15/2017Sell9,576$55.00$526,680.0016,319View SEC Filing Icon  
See Full Table

Prahlad R. Singh Buying and Selling Activity at Revvity

This chart shows Prahlad R Singh's buying and selling at Revvity by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Revvity Company Overview

Revvity logo
Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $127.73
Low: $115.24
High: $137.11

2 Week Range

Now: N/A

Volume

1,633,000 shs

Average Volume

851,117 shs

Market Capitalization

$14.57 billion

P/E Ratio

15.01

Dividend Yield

0.24%

Beta

1.1